Supernus Pharmaceuticals, Inc.
SUPNFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Supernus Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Mar 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 5,089 | $252K | SEC filing |
| Bruce & Co., Inc. | 2026-03-31 | 100,000 | $5.17M | SEC filing |
| Atom Investors LP | 2026-03-31 | 45,749 | $2.36M | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 2,991 | $155K | SEC filing |
| Swiss National Bank | 2026-03-31 | 113,500 | $5.87M | SEC filing |
| Legal & General Group Plc | 2026-03-31 | 135,810 | $7.02M | SEC filing |
| FMR LLC | 2026-03-31 | 209,370 | $10.8M | SEC filing |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 2026-03-31 | 40,322 | $2.08M | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 2026-03-31 | 7,841 | Not shown | SEC filing |
| Polaris Capital Management, LLC | 2026-03-31 | 22,500 | $1.16M | SEC filing |
| Ellsworth Advisors, LLC | 2026-03-31 | 16,842 | $871K | SEC filing |
| MATHER GROUP, LLC. | 2026-03-31 | 110 | $5.69K | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 2026-03-31 | 522 | $27K | SEC filing |
| State of Tennessee, Department of Treasury | 2026-03-31 | 12,316 | $637K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 377,213 | Not shown | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 90,821 | $4.69M | SEC filing |
| Covestor Ltd | 2026-03-31 | 867 | Not shown | SEC filing |
| Sound Income Strategies, LLC | 2026-03-31 | 287 | $14.8K | SEC filing |
| CoreCap Advisors, LLC | 2026-03-31 | 399 | $20.6K | SEC filing |
| Phocas Financial Corp. | 2026-03-31 | 63,413 | $3.28M | SEC filing |
- Each value is checked against Supernus Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Supernus Pharmaceuticals, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Supernus Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-10-09 · Khattar Jack A.: Larger than 45 of the 46 other insider sales of Common Stock on file. SEC filing
- 2025-10-01 · Khattar Jack A.: Larger than 43 of the 46 other insider sales of Common Stock on file. SEC filing
- 2025-09-05 · Khattar Jack A.: Larger than 44 of the 46 other insider sales of Common Stock on file. SEC filing
- 2025-08-06 · Khattar Jack A.: Larger than 42 of the 46 other insider sales of Common Stock on file. SEC filing
- 2025-08-06 · Khattar Jack A.: Larger than all 46 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-18 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −6,838 | 49.55 | SEC filing |
| 2026-03-18 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −412 | 50.48 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −27,710 | 49.95 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −22,290 | 50.73 | SEC filing |
| 2026-03-16 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −34,114 | 50.18 | SEC filing |
| 2026-03-16 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | S — Open market or private sale | −15,886 | 50.49 | SEC filing |
| 2026-03-13 | Khattar Jack A. · President, CEO | Common Stock | S — Open market or private sale | −120 | 51.75 | SEC filing |
| 2026-03-13 | Khattar Jack A. · President, CEO | Common Stock | S — Open market or private sale | −10,742 | 51.00 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-18 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | M — Exercise or conversion of derivative security | +7,250 | SEC filing |
| 2026-03-18 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −7,250 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | M — Exercise or conversion of derivative security | +12,250 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −22,750 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | M — Exercise or conversion of derivative security | +22,750 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −12,250 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −15,000 | SEC filing |
| 2026-03-17 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Common Stock | M — Exercise or conversion of derivative security | +15,000 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-13 | Khattar Jack A. · President, CEO | Common Stock | J — Other acquisition or disposition | −12,500 | SEC filing |
| 2026-03-13 | Khattar Jack A. · President, CEO | Common Stock | J — Other acquisition or disposition | +12,500 | SEC filing |
| 2026-02-25 | Bhatt Padmanabh P. · Sr. VP of IP, CSO | Restricted Stock Unit | D — Disposition to the issuer | −1,250 | SEC filing |
| 2026-02-25 | Rubin Jonathan · SVP, Chief Medical Officer | Restricted Stock Unit | D — Disposition to the issuer | −1,250 | SEC filing |
| 2026-02-25 | Mottola Frank · SVP, Chief Tech. Ops. Officer | Restricted Stock Unit | D — Disposition to the issuer | −1,875 | SEC filing |
| 2026-02-25 | DEC TIMOTHY C · Senior Vice-President & CFO | Restricted Stock Unit | D — Disposition to the issuer | −2,500 | SEC filing |
| 2026-02-24 | DEC TIMOTHY C · Senior Vice-President & CFO | Restricted Stock Unit | D — Disposition to the issuer | −3,000 | SEC filing |
| 2026-02-24 | Mottola Frank · SVP, Chief Tech. Ops. Officer | Restricted Stock Unit | D — Disposition to the issuer | −750 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.